Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment.
Transpl Int
; 27(4): 371-82, 2014 Apr.
Article
en En
| MEDLINE
| ID: mdl-24438437
Palabras clave
B-cell targeting protocol; B-cell-activating factor belonging to the tumor necrosis factor family; acute antibody-mediated rejection; anti-HLA antibodies; chronic antibody-mediated rejection; de novo antibodies; desensitization protocol; graft loss; graft survival rate; renal transplantation; rituximab
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Trasplante de Riñón
/
Anticuerpos Monoclonales de Origen Murino
/
Supervivencia de Injerto
/
Antígenos HLA
/
Isoanticuerpos
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Transpl Int
Asunto de la revista:
TRANSPLANTE
Año:
2014
Tipo del documento:
Article
País de afiliación:
Japón